{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:29:22Z","timestamp":1778675362006,"version":"3.51.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/ftd.0b013e3182608e2f","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T12:50:06Z","timestamp":1340887806000},"page":"406-414","source":"Crossref","is-referenced-by-count":11,"title":["Effect of Short- and Long-Term Treatment With Valproate on Carnitine Homeostasis in Humans"],"prefix":"10.1097","volume":"34","author":[{"given":"R\u00e9jane","family":"Morand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Todesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fischer-Barnicol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Kr\u00e4henb\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.48.1.182","article-title":"Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group.","volume":"48","author":"Beydoun","year":"1997","journal-title":"Neurology"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":". The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jad.2009.11.008","article-title":"Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis.","volume":"124","author":"Bond","year":"2010","journal-title":"J Affect Disord"},{"issue":"suppl 1","key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/s10072-010-0268-7","article-title":"Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.","volume":"31","author":"DAmico","year":"2010","journal-title":"Neurol Sci"},{"issue":"suppl 2","key":"R5-8-20210129","first-page":"25","article-title":"Pharmacokinetics, drug interactions, and tolerability of valproate.","volume":"37","author":"DeVane","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(94)00424-4","article-title":". Determination of urinary valproylcarnitine by gas chromatography-mass spectrometry with selected-ion monitoring.","volume":"663","author":"Muro","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1528-1157.1996.tb00634.x","article-title":". Effect of L-carnitine supplementation on acute valproate intoxication.","volume":"37","author":"Murakami","year":"1996","journal-title":"Epilepsia"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0009-8981(85)90020-8","article-title":". Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry.","volume":"145","author":"Millington","year":"1985","journal-title":"Clin Chim Acta"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01377353","article-title":". Decreased serum carnitine in valproate induced Reye syndrome.","volume":"139","author":"Bohles","year":"1982","journal-title":"Eur J Pediatr"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic acid therapy.","volume":"101","author":"Ohtani","year":"1982","journal-title":"J Pediatr"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-3476(83)80831-2","article-title":"Carnitine deficiency with valproate therapy.","volume":"103","author":"Stumpf","year":"1983","journal-title":"J Pediatr"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2009.04.002","article-title":"The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.","volume":"86","author":"Hamed","year":"2009","journal-title":"Epilepsy Res"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.psy.49.1.82","article-title":"Severe acute hyperammonemia after brief exposure to valproate.","volume":"49","author":"Eubanks","year":"2008","journal-title":"Psychosomatics"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1469-8749.1991.tb14963.x","article-title":". Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.","volume":"33","author":"Thom","year":"1991","journal-title":"Dev Med Child Neurol"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.braindev.2005.11.005","article-title":". Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.","volume":"28","author":"Coppola","year":"2006","journal-title":"Brain Dev"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1542\/peds.101.5.e9","article-title":". Valproate therapy does not deplete carnitine levels in otherwise healthy children.","volume":"101","author":"Hirose","year":"1998","journal-title":"Pediatrics"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0009-9120(01)00272-7","article-title":". Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MSMS.","volume":"34","author":"Silva","year":"2001","journal-title":"Clin Biochem"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00044-5","article-title":"Fatty acid import into mitochondria.","volume":"1486","author":"Kerner","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1748-1716.1955.tb01256.x","article-title":"The effect of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates.","volume":"34","author":"Fritz","year":"1955","journal-title":"Acta Physiol Scand"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1073\/pnas.54.4.1226","article-title":"The role of acylcarnitine esters and carnitine palmityltransferase in the transport of fatty acyl groups across mitochondrial membranes.","volume":"54","author":"Fritz","year":"1965","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/bj1900495","article-title":"Relationship between acid-soluble carnitine and coenzyme A pools in vivo.","volume":"190","author":"Brass","year":"1980","journal-title":"Biochem J"},{"key":"R22-8-20210129","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI117488","article-title":"Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions.","volume":"94","author":"Friolet","year":"1994","journal-title":"J Clin Invest"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitinemetabolism and functions.","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol Rev"},{"key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ndt\/gfi257","article-title":". Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis.","volume":"21","author":"Vernez","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002280050504","article-title":". Increased urinary excretion of carnitine in patients treated with cisplatin.","volume":"54","author":"Heuberger","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1053\/jhep.2000.8105","article-title":"Decreased carnitine biosynthesis in rats with secondary biliary cirrhosis.","volume":"31","author":"Krahenbuhl","year":"2000","journal-title":"Hepatology"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/hep.510250127","article-title":"Carnitine metabolism in patients with chronic liver disease.","volume":"25","author":"Krahenbuhl","year":"1997","journal-title":"Hepatology"},{"key":"R28-8-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/5030","article-title":". Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.","volume":"21","author":"Nezu","year":"1999","journal-title":"Nat Genet"},{"key":"R29-8-20210129","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1007\/s00018-008-8065-7","article-title":". Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2.","volume":"65","author":"Todesco","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"R30-8-20210129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ndt\/gfp456","article-title":". Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.","volume":"25","author":"Haschke","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R31-8-20210129","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/clinchem\/48.6.826","article-title":". Analysis of carnitine biosynthesis metabolites in urine by HPLC-electrospray tandem mass spectrometry.","volume":"48","author":"Vaz","year":"2002","journal-title":"Clin Chem"},{"key":"R32-8-20210129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0026-0495(99)90013-6","article-title":". Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans.","volume":"48","author":"Stadler","year":"1999","journal-title":"Metabolism"},{"key":"R33-8-20210129","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0006-2952(96)00507-2","article-title":". Inhibition of carnitine biosynthesis by valproic acid in ratsthe biochemical mechanism of inhibition.","volume":"52","author":"Farkas","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"R34-8-20210129","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1021\/jo01287a057","article-title":"O-acylation of dl-carnitine chloride.","volume":"32","author":"Ziegler","year":"1967","journal-title":"J Org Chem"},{"key":"R35-8-20210129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cbi.2009.02.014","article-title":". Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.","volume":"180","author":"Todesco","year":"2009","journal-title":"Chem Biol Interact"},{"key":"R36-8-20210129","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9673(02)01838-1","article-title":". Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography-electrospray ionization ion trap tandem mass spectrometry.","volume":"984","author":"Vernez","year":"2003","journal-title":"J Chromatogr A"},{"key":"R37-8-20210129","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/rcm.1470","article-title":"Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatographyelectrospray ionization ion trap tandem mass spectrometry.","volume":"18","author":"Vernez","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R38-8-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.nu.06.070186.000353","article-title":"Carnitine metabolism and function in humans.","volume":"6","author":"Rebouche","year":"1986","journal-title":"Annu Rev Nutr"},{"issue":"pt 2","key":"R39-8-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/bj3090643","article-title":"Characterization of L-carnitine transport by rat kidney brush-border-membrane vesicles.","volume":"309","author":"Stieger","year":"1995","journal-title":"Biochem J"},{"key":"R40-8-20210129","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","article-title":". Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.","volume":"273","author":"Tamai","year":"1998","journal-title":"J Biol Chem"},{"key":"R41-8-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ajcn\/50.2.301","article-title":". Carnitine status of lactoovovegetarians and strict vegetarian adults and children.","volume":"50","author":"Lombard","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"R42-8-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2010.02.045","article-title":". The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats.","volume":"635","author":"Schurch","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"R43-8-20210129","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1248\/bpb.31.1230","article-title":". Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha.","volume":"31","author":"Maeda","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"R44-8-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.phrs.2007.06.001","article-title":". Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.","volume":"56","author":"Ringseis","year":"2007","journal-title":"Pharmacol Res"},{"key":"R45-8-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/03602538708994130","article-title":". The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.","volume":"18","author":"Hawkins","year":"1987","journal-title":"Drug Metab Rev"},{"key":"R46-8-20210129","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0006-2952(85)90670-7","article-title":"Enhancement of peroxisomal beta-oxidation in the liver of rats and mice treated with valproic acid.","volume":"34","author":"Horie","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"R47-8-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2133\/dmpk.23.293","article-title":". Role of NaL-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment.","volume":"23","author":"Ohnishi","year":"2008","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e3182608e2f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T21:22:28Z","timestamp":1743628948000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201208000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3182608e2f","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}